Search results for:
paliperidone
paliperidone
| Drug Name |
Form |
Strength |
Ambulatory Use Only |
Ambulatory Restrictions |
Inpatient Restrictions |
Non-Formulary |
| Invega Sustenna |
SUSPENSION, EXTENDED RELEASE, INTRAMUSCULAR |
39 mg/0.25 mL; 78 mg/0.5 mL; 117 mg/0.75 mL; 156 mg/mL; 234 mg/1.5 mL |
|
|
|
|
| Invega |
TABLET, EXTENDED RELEASE, ORAL |
1.5 mg; 3 mg; 6 mg |
|
|
|
|
Last updated: Feb. 5, 2024
**Invega Sustenna is approved for use in the outpatient setting. Inpatient use restricted and must meet Tier 1 criteria**